Back
Globe Life, Inc. 10K Form
Sell
43
GL
Globe Life, Inc.
Last Price:
$130.87
Seasonality Move:
3.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-05-07 | 10Q | GL/Globe Life, Inc. Quarterly |
| 2020-02-27 | 10K | GL/Globe Life, Inc. Annual |
| 2019-11-12 | 10Q | GL/Globe Life, Inc. Quarterly |
| 2019-08-08 | 10Q | GL/Globe Life, Inc. Quarterly |
| 2019-05-07 | 10Q | GL/Globe Life, Inc. Quarterly |
| 2019-03-01 | 10K | GL/Globe Life, Inc. Annual |
Receive GL News And Ratings
See the #1 stock for the next 7 days that we like better than GL
GL Financial Statistics
Sales & Book Value
| Annual Sales: | $5.8B |
|---|---|
| Cash Flow: | $208.7M |
| Price / Cash Flow: | 8.77 |
| Annual Sales: | $70.84 |
| Price / Book: | 1.83 |
Profitability
| EPS (TTM): | 13.80620 |
|---|---|
| Net Income (TTM): | $1.2B |
| Gross Margin: | $0 |
| Return on Equity: | 21.72% |
| Return on Assets: | 3.87% |
Globe Life, Inc. Earnings Forecast
Key Globe Life, Inc. Financial Ratios
-
The Gross Profit Margin over the past 45 years for GL is 0.00%.
-
The Selling, General & Administrative Expenses for GL have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 11.87% of Operating Income.
-
The Net Earning history of GL is 18.53% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 35 years.
Globe Life, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | GL |
| CUSIP: | 37959E |
| Website: | globelifeinsurance.com |
Debt
| Debt-to-Equity Ratio: | 0.48 |
|---|---|
| Current Ratio: | 0.87 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 10.95 |
|---|---|
| Forward P/E Ratio: | 8.72 |
GL Technical Analysis vs Fundamental Analysis
Sell
43
Globe Life, Inc. (GL)
is a Sell
Is Globe Life, Inc. a Buy or a Sell?
-
Globe Life, Inc. stock is rated a SellThe current Globe Life, Inc. [GL] share price is $130.82. The Score for GL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.